Mutia, Fernanda .

HRN: 20-20-30  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/18/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/18/2026
03/18/2026
IV
4.5G
LD
CAP-MR
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: